Stroke Trial, Recruiting NCT07556068 Sponsor: Beijing Shijitan Hospital, Capital Medical University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07556068
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) affecting a major artery at the front of the brain, confirmed by a scan (CTA, MRA, or DSA)
  • People whose stroke severity score (NIHSS) was 6 or higher before their procedure
  • People who were largely independent before this stroke, with little to no disability (Modified Rankin Scale score of 1 or less)
  • People who have already received an endovascular treatment (a procedure to unblock the artery) within 24 hours of their stroke, and where that treatment successfully restored blood flow to a satisfactory level
  • People whose brain scan shows limited damage (ASPECTS score of 3 or higher); for strokes that began between 6 and 24 hours before treatment, the person must also be aged 80 or under
  • Cases where the patient or their legally authorised representative has signed the consent form

Who may not be able to join:

  • People whose scans show a stroke affecting more than one blood vessel territory in the brain at the same time
  • People whose scans show a torn or split artery (arterial dissection)
  • People who had any bleeding in the brain before the unblocking procedure
  • People with known allergies or intolerances to blood-thinning medications, iodine-based contrast dye, or anaesthetics
  • People with a serious active infection (such as sepsis) or failure of multiple organs
  • People with a known bleeding disorder or clotting deficiency, or whose blood-thinning medication levels are outside the accepted range (confirm specific thresholds with trial site)
  • People with a very low platelet count (below 50 × 10⁹/L) — platelets are cells that help blood clot
  • People whose blood sugar level is either very low or very high at the time of the stroke
  • People with very high blood pressure that cannot be brought under control with medication
  • People with severe heart failure, a recent heart attack, or unstable chest pain
  • People with untreated moderate or severe narrowing of the heart's arteries, or who have previously had coronary artery bypass surgery
  • People currently receiving kidney dialysis, or with severely reduced kidney function
  • People with a known brain aneurysm (a bulge in a blood vessel) or an abnormal tangle of blood vessels in the brain
  • People with a malignant brain tumour or an active infection of the brain or nervous system
  • People with a pre-existing neurological or psychiatric condition (such as dementia) that would affect the ability to assess stroke recovery
  • People who are pregnant or breastfeeding at the time of admission
  • People whose life expectancy is estimated to be less than 6 months
  • People currently taking part in another clinical trial involving an investigational drug or device
  • People with skin damage or other conditions that would prevent medical patches or electrodes from being applied to the skin
  • People with severe agitation or other conditions that would interfere with data collection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shen Li, Beijing Shijitan Hospital, Capital Medical University

Phone: 010-63925615

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Shijitan Hospital, Capital Medical University
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
15 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The sensitivity, specificity and area under the receiver operating characteristic curve for percentage of Modified Rankin scale 0-2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov